<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00712621</url>
  </required_header>
  <id_info>
    <org_study_id>ASI-QOLII0608</org_study_id>
    <secondary_id>ASI-QOL8655</secondary_id>
    <nct_id>NCT00712621</nct_id>
  </id_info>
  <brief_title>Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination</brief_title>
  <official_title>Phase II Two Arm Randomized Controlled Clinical Trial to Study Quality of Life and Survival of Breast Cancer Patients After Completion of Chemotherapy or Radiation Therapy or Surgery or Any Combination Therapy in Stage I to IV Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Scitech International</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American Scitech International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Determining quality of life in breast cancer patient after completing chemotherapy&#xD;
      or radiation therapy or surgical procedures or any combination therapy.&#xD;
&#xD;
      Intervention includes supportive care in terms of psychological support and moral boosting&#xD;
      efforts by counseling breast cancer survivors which may enhance the well-being and quality of&#xD;
      life of women who are treated with chemotherapy or radiation therapy or surgical procedures&#xD;
      or any given combination therapy.&#xD;
&#xD;
      PURPOSE: Randomized clinical trial study to compare the effectiveness of support system and&#xD;
      counseling of breast cancer survivors on the well-being of women, who have completed various&#xD;
      modes of treatment of breast cancer with the subjects who have no support system.&#xD;
&#xD;
      Study Type: Quality of life and survival&#xD;
&#xD;
      Study Design: Two arm randomized controlled clinical trial to study quality of life and&#xD;
      survival of breast cancer patients after completion of chemotherapy or radiation therapy or&#xD;
      surgery or any combination therapy. The stages from I to IV (metastases to other sites of the&#xD;
      body) are included.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Determine the quality of life in breast cancer patient after completing chemotherapy or&#xD;
           radiation therapy or surgical procedures or any combination therapy in both Arms.&#xD;
&#xD;
        -  Determine the effect of providing standard written materials in Arm I.&#xD;
&#xD;
        -  Determine the effect of psychological support and moral boosting efforts by counseling&#xD;
           breast cancer survivors which may enhance the well-being and quality of life of women&#xD;
           who are treated with chemotherapy or radiation therapy or surgical procedures or any&#xD;
           combination therapy in Arm II.&#xD;
&#xD;
        -  Determine the effect of socioeconomic status on all available demographic area which is&#xD;
           not a criteria for exclusion in both Arms.&#xD;
&#xD;
        -  Determine psychosocial and mental state to measure wellness and good quality of life in&#xD;
           both Arms.&#xD;
&#xD;
        -  Determine the periodic medical care for related or unrelated problems of the disease&#xD;
           which have a positive impact on the survival and quality of life in both Arms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study is withdrawn due to unavailability of eligible subject population. We will request the&#xD;
    sponsors to extend the time for enrollment.&#xD;
  </why_stopped>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure: Psychological assessment and discussion on social &amp; economic issues and medical problems related or unrelated to the therapy; quality-of-life assessment; long term survival</measure>
    <time_frame>2-4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long term disease free survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>OUTLINE: This is a randomized, multicenter study. Patients are selected according to age ( 25 to 49 vs 50 to 85), time since initial completion of therapy (3 to 18 months), and are separated in two groups.&#xD;
Arm I: Quality of life is assessed at baseline and at 3 and 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>OUTLINE: This is a randomized, multicenter study. Patients are selected according to age ( 25 to 49 vs 50 to 85), time since initial completion of therapy (3 to 18 months), and are separated in two groups.&#xD;
Arm II: Quality of life is assessed at baseline and at 3 and 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counseling</intervention_name>
    <description>• Arm II: Patients receive audio visual aids and weekly counseling sessions by the expert counselors and breast cancer survivors over 8 weeks for a total of 8-16 sessions. Patients receive written materials from the counseling group after the completion of the sessions</description>
    <arm_group_label>II</arm_group_label>
    <other_name>Lifestyle Counseling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written materials</intervention_name>
    <description>• Arm I: Patients receive the support by providing existing resources. Patients receive standard written materials from the counseling group after enrolling in the study.</description>
    <arm_group_label>I</arm_group_label>
    <other_name>Quality of Life</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Breast cancer patients&#xD;
&#xD;
          -  25 to 85 years old&#xD;
&#xD;
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Received prior definitive treatment for stage I-IV breast cancer with or without&#xD;
             adjuvant chemotherapy or radiation therapy or surgical therapy or any combination&#xD;
             therapy.&#xD;
&#xD;
          -  3 to 18 months since completion therapy.&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age:&#xD;
&#xD;
          -  25 to 49 vs 50 to 85&#xD;
&#xD;
        Sex:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
        Menopausal status:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Performance status:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic:&#xD;
&#xD;
          -  CBC in normal range:&#xD;
&#xD;
          -  Hemoglobin - 10 g/dl&#xD;
&#xD;
          -  Blood Glucose is twofold above the normal range&#xD;
&#xD;
        Hepatic:&#xD;
&#xD;
          -  Hepatic profile is twofold above the normal range:&#xD;
&#xD;
          -  AST/ALT&#xD;
&#xD;
          -  Bilirubin,total&#xD;
&#xD;
          -  Protein (Albumin, Globulin)&#xD;
&#xD;
        Renal:&#xD;
&#xD;
          -  Renal tests are twofold above the normal range:&#xD;
&#xD;
          -  Creatinine clearance 24 hours&#xD;
&#xD;
          -  BUN&#xD;
&#xD;
          -  Creatinine level&#xD;
&#xD;
        Other:&#xD;
&#xD;
          -  No current psychiatric diagnosis&#xD;
&#xD;
          -  Mini Mental Status Examination&#xD;
&#xD;
          -  No signs and symptoms MDD&#xD;
&#xD;
          -  Anxiety disorder&#xD;
&#xD;
          -  Post Traumatic Syndrome Disorder&#xD;
&#xD;
        Status of Therapy:&#xD;
&#xD;
        Chemotherapy:&#xD;
&#xD;
          -  Completed&#xD;
&#xD;
        Endocrine therapy:&#xD;
&#xD;
          -  Completed&#xD;
&#xD;
        Radiotherapy:&#xD;
&#xD;
          -  Completed&#xD;
&#xD;
        Surgery:&#xD;
&#xD;
          -  Completed at least three months before the start of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age below 25 and above 85&#xD;
&#xD;
          -  Subject with breast carcinoma in therapy&#xD;
&#xD;
          -  Any current mental illness&#xD;
&#xD;
          -  Hepatic enzymes are more than twofold from the normal range&#xD;
&#xD;
          -  Renal impairment is more than twofold from the normal range&#xD;
&#xD;
          -  Hemoglobin is less than 10 g/dl&#xD;
&#xD;
          -  CBC results are below normal range&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prem A Nandiwada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raritan Bay Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ratna Grewal, MD</last_name>
    <role>Study Chair</role>
    <affiliation>American Scitech International-eCRO</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarat Babu, MD</last_name>
    <role>Study Director</role>
    <affiliation>St. Peter's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Practicing physician in New Jersey</name>
      <address>
        <city>Englishtown</city>
        <state>New Jersey</state>
        <zip>07726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.americanscitech.com</url>
    <description>Web based electronic data capture research center; Contract Research Organization</description>
  </link>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>June 18, 2008</study_first_submitted>
  <study_first_submitted_qc>July 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2008</study_first_posted>
  <last_update_submitted>November 20, 2009</last_update_submitted>
  <last_update_submitted_qc>November 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Ratna Grewal</name_title>
    <organization>American Scitech International</organization>
  </responsible_party>
  <keyword>Genetics Home Reference related topics</keyword>
  <keyword>breast cancer</keyword>
  <keyword>breast cancer related to depression</keyword>
  <keyword>Condition</keyword>
  <keyword>Stage I-IV Carcinoma of Breast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

